世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
炎症性眼疾患の発生率の増加、ぶどう膜炎治療薬の製品パイプラインの充実が世界市場を牽引するIncreasing incidence of inflammatory eye diseases and growing product pipeline for uveitis treatment will drive the global market ぶどう膜炎治療薬の市場報告書の範囲 Persistence Market Research社の調査レポート「世界のぶどう膜炎治療市場」は、機会や現在の市場環境を評価し、詳細な分析、市場に影響を与える対応セクションに関する最... もっと見る
サマリーぶどう膜炎治療薬の市場報告書の範囲Persistence Market Research社の調査レポート「世界のぶどう膜炎治療市場」は、機会や現在の市場環境を評価し、詳細な分析、市場に影響を与える対応セクションに関する最新情報を提供します。この調査は、市場の促進要因、阻害要因、動向、機会を含む現在の市場力学に関する詳細な洞察を提供します。この市場調査の主な目的は、2023年から2033年の予測期間中に市場がどのように推移するかについての独占情報を提示することです。 市場の成功的な成長のための重要な指標は、市場の前年比（YoY）成長分析、複合年間成長率（CAGR）を含むこの包括的なレポートで提示されており、Persistence Market Researchの調査において網羅的に説明されているものである。この調査研究は、読者が研究期間中のぶどう膜炎治療製品の需要と定量的な開発機会を知るためのサポートとなります。 この調査は、投資家、メーカー、サービスプロバイダー、流通業者、サプライヤーなどのランドスケープの株主にとって有益であり、ぶどう膜炎治療市場で繁栄するための適切なビジネス戦略を開発するのに役立ちます。ぶどう膜炎治療市場の株主、業界専門家、投資家、研究者、記者、ビジネス愛好家は、このPersistence Market Researchの調査で示された洞察と情報を活用できます。 市場統計、ならびにぶどう膜炎治療市場のビジネスシナリオに影響を与えるマクロ経済変数だけでなくマクロ経済変数に関連する情報も、今回の調査に含まれています。市場の潜在的な発展に応じて、実質的な洞察も本レポートで遭遇することができます。さらに、本レポートで提出されたデータにより、業界のマイナーな企業や新規参入者は、市場で牽引力を発揮するために適切な企業選択をする際に役立つことができます。 主要な市場セグメント Persistence Market Research社のぶどう膜炎治療市場に関する調査レポートは、治療、疾患、原因、流通チャネル、地域の5つの重要なセグメントに分けられた情報を提供しています。本レポートでは、これらのカテゴリーに関連する重要な市場力学と成長パラメータに関する包括的なデータと情報を提供します。 治療薬 副腎皮質ホルモン剤 免疫抑制剤 モノクローナル抗体 サイクロプレンギック薬 抗生物質 抗ウイルス剤 抗真菌剤 鎮痛剤 疾患別 前部ぶどう膜炎 後方ぶどう膜炎 中間ぶどう膜炎 汎ぶどう膜炎 原因 感染性ぶどう膜炎 非感染性ぶどう膜炎 販売チャネル 病院薬局 小売薬局 オンライン薬局 ドラッグストア 地域別 北アメリカ 中南米 ヨーロッパ 南アジア 東アジア オセアニア 中東・アフリカ(MEA) 報告書に記載されている主な質問 今後数年間、ぶどう膜炎治療で最も収益性の高い市場を維持し続けるのはどの地域か？ トレンドの変化は市場にどのような影響を与えるか？ COVID-19危機は市場の成長にどのような影響を与えたか？ 市場関係者はどのようにして先進国の低空飛行の機会を獲得することができるのか？ 市場関係者は、このランドスケープにおける自らのポジションを形成するために、どのような戦略を持っているのか？ 投資家が市場に投資する際に意識する必要があり、取り組む可能性がある抑制要因は何か？ 市場に影響を与える開発動向は何か？ ぶどう膜炎治療薬市場の企業は、先進国および新興国の成長機会をどのように利用できるのか？ 調査方法 Persistence Market Research社の調査レポートでは、ぶどう膜炎治療市場の成長に関する広範な調査を実施し、市場の将来の成長パラメータに関する結論を得るために、独自の調査手法を利用しています。この調査手法は、一次調査と二次調査を組み合わせたもので、アナリストが結論の正確性と信頼性を確保するのに役立ちます。 市場調査作成時にアナリストが参照した二次資料には、政府機関の統計、業界誌、白書、社内外の独自データベースなどがあります。アナリストは、一次資料として、本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行った。 一次および二次リソースから取得した包括的な情報は、市場内の企業からの検証として機能し、ぶどう膜炎治療市場の成長見通しに関するPersistence Market Researchの予測をより正確で信頼性の高いものにします。 目次1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Treatment Adoption / Analysis 4.2. Disease Epidemiology 4.3. Pipeline Assessment 4.4. Patient Journey Analysis 4.5. PESTLE Analysis 4.6. Regulatory Scenario 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.1.3. Global Retinal Disorder Treatment Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Rise in Autoimmune Diseases 5.2.2. Rise in Infectious Uveitis 5.2.3. Treatment Adoption Rate 5.2.4. Growing Number of Service Providers 5.2.5. Rise in Infectious Illness Frequency in Developing Nations 5.2.6. Mergers and Acquisitions 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis - Impact Assessment 6.1. COVID-19 and Impact Analysis 6.1.1. By Treatment 6.1.2. By Disease 6.1.3. By Cause 6.1.4. By Distribution Channel 6.1.5. By Region 6.2. 2022 Market Scenario 7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2014-2022and Forecast, 2023-2033 7.1. Historical Market Value (US$ Mn) Analysis, 2014-2022 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2014-2022and Forecast 2023-2033, By Treatment 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Treatment, 2014-2022 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment, 2023-2033 8.3.1. Corticosteroids 8.3.2. Immunosuppressant 8.3.3. Monoclonal Antibodies 8.3.4. Cycloplegic Agents 8.3.5. Antibiotics 8.3.6. Antivirals 8.3.7. Antifungal 8.3.8. Analgesics 8.4. Market Attractiveness Analysis By Treatment 9. Global Market Analysis 2014-2022and Forecast 2023-2033, By Disease 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Disease, 2014-2022 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease, 2023-2033 9.3.1. Anterior Uveitis 9.3.2. Posterior Uveitis 9.3.3. Intermediate Uveitis 9.3.4. Panuveitis 9.4. Market Attractiveness Analysis By Disease 10. Global Market Analysis 2014-2022and Forecast 2023-2033, By Cause 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Cause, 2014-2022 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cause, 2023-2033 10.3.1. Infectious Uveitis 10.3.2. Non-infectious Uveitis 10.4. Market Attractiveness Analysis By Cause 11. Global Market Analysis 2014-2022and Forecast 2023-2033, by Distribution Channel 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2022 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2023-2033 11.3.1. Hospital Pharmacies 11.3.2. Retail Pharmacies 11.3.3. Online Pharmacies 11.3.4. Drug Stores 11.4. Market Attractiveness Analysis By Distribution Channel 12. Global Market Analysis 2014-2022and Forecast 2023-2033, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2022 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. South Asia 12.3.5. East Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2014-2022and Forecast 2023-2033 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Treatment 13.3.3. By Disease 13.3.4. By Cause 13.3.5. By Distribution Channel 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Treatment 13.4.3. By Disease 13.4.4. By Cause 13.4.5. By Distribution Channel 13.5. Country Level Analysis & Forecast 13.5.1. U.S. Market Analysis 13.5.1.1. . Introduction 13.5.1.2. Market Analysis and Forecast by Market Taxonomy 13.5.1.2.1. By Treatment 13.5.1.2.2. By Disease 13.5.1.2.3. By Cause 13.5.1.2.4. By Distribution Channel 13.5.2. Canada Market Analysis 13.5.2.1. Introduction 13.5.2.2. Market Analysis and Forecast by Market Taxonomy 13.5.2.2.1. By Treatment 13.5.2.2.2. By Disease 13.5.2.2.3. By Cause 13.5.2.2.4. By Distribution Channel 13.6. Market Trends 13.7. Key Market Participants - Intensity Mapping 13.8. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2014-2022 and Forecast 2023-2033 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.1.4.1. By Treatment 14.3.1.4.2. By Disease 14.3.1.4.3. By Cause 14.3.1.4.4. By Distribution Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Treatment 14.4.3. By Distribution Channel 14.5. Country Level Analysis & Forecast 14.5.1. Brazil Market Analysis 14.5.1.1. . Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Treatment 14.5.1.2.2. By Disease 14.5.1.2.3. By Cause 14.5.1.2.4. By Distribution Channel 14.5.2. Mexico Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Treatment 14.5.2.2.2. By Disease 14.5.2.2.3. By Cause 14.5.2.2.4. By Distribution Channel 14.5.3. Argentina Market Analysis 14.5.3.1. Introduction 14.5.3.2. Market Analysis and Forecast by Market Taxonomy 14.5.3.2.1. By Treatment 14.5.3.2.2. By Disease 14.5.3.2.3. By Cause 14.5.3.2.4. By Distribution Channel 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2014-2022and Forecast 2023-2033 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. France 15.3.1.3. Italy 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. BENELUX 15.3.1.8. Nordic Countries 15.3.1.9. Rest of Europe 15.3.2. By Treatment 15.3.3. By Disease 15.3.4. By Cause 15.3.5. By Distribution Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Treatment 15.4.3. By Disease 15.4.4. By Cause 15.4.5. By Distribution Channel 15.5. Country Level Analysis & Forecast 15.5.1. Germany Market Analysis 15.5.1.1. . Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Treatment 15.5.1.2.2. By Disease 15.5.1.2.3. By Cause 15.5.1.2.4. By Distribution Channel 15.5.2. France Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Treatment 15.5.2.2.2. By Disease 15.5.2.2.3. By Cause 15.5.2.2.4. By Distribution Channel 15.5.3. Italy Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Treatment 15.5.3.2.2. By Disease 15.5.3.2.3. By Cause 15.5.3.2.4. By Distribution Channel 15.5.4. U.K. Market Analysis 15.5.4.1. . Introduction 15.5.4.2. Market Analysis and Forecast by Market Taxonomy 15.5.4.2.1. By Treatment 15.5.4.2.2. By Disease 15.5.4.2.3. By Cause 15.5.4.2.4. By Distribution Channel 15.5.5. Spain Market Analysis 15.5.5.1. . Introduction 15.5.5.2. Market Analysis and Forecast by Market Taxonomy 15.5.5.2.1. By Treatment 15.5.5.2.2. By Disease 15.5.5.2.3. By Cause 15.5.5.2.4. By Distribution Channel 15.5.6. Russia Market Analysis 15.5.6.1. . Introduction 15.5.6.2. Market Analysis and Forecast by Market Taxonomy 15.5.6.2.1. By Treatment 15.5.6.2.2. By Disease 15.5.6.2.3. By Cause 15.5.6.2.4. By Distribution Channel 15.5.7. Nordic Countries Market Analysis 15.5.7.1. . Introduction 15.5.7.2. Market Analysis and Forecast by Market Taxonomy 15.5.7.2.1. By Treatment 15.5.7.2.2. By Disease 15.5.7.2.3. By Cause 15.5.7.2.4. By Distribution Channel 15.5.8. BENELUX Market Analysis 15.5.8.1. . Introduction 15.5.8.2. Market Analysis and Forecast by Market Taxonomy 15.5.8.2.1. By Treatment 15.5.8.2.2. By Disease 15.5.8.2.3. By Cause 15.5.8.2.4. By Distribution Channel 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2014-2022and Forecast 2023-2033 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Treatment 16.3.3. By Disease 16.3.4. By Cause 16.3.5. By Distribution Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Treatment 16.4.3. By Disease 16.4.4. By Cause 16.4.5. By Distribution Channel 16.5. Country Level Analysis & Forecast 16.5.1. India Market Analysis 16.5.1.1. . Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Treatment 16.5.1.2.2. By Disease 16.5.1.2.3. By Cause 16.5.1.2.4. By Distribution Channel 16.5.2. Thailand Market Analysis 16.5.2.1. . Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Treatment 16.5.2.2.2. By Disease 16.5.2.2.3. By Cause 16.5.2.2.4. By Distribution Channel 16.5.3. Indonesia Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Treatment 16.5.3.2.2. By Disease 16.5.3.2.3. By Cause 16.5.3.2.4. By Distribution Channel 16.5.4. Malaysia Market Analysis 16.5.4.1. Introduction 16.5.4.2. Market Analysis and Forecast by Market Taxonomy 16.5.4.2.1. By Treatment 16.5.4.2.2. By Disease 16.5.4.2.3. By Cause 16.5.4.2.4. By Distribution Channel 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. East Asia Market Analysis 2014-2022and Forecast 2023-2033 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Treatment 17.3.3. By Disease 17.3.4. By Cause 17.3.5. By Distribution Channel 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Treatment 17.4.3. By Disease 17.4.4. By Cause 17.4.5. By Distribution Channel 17.5. Country Level Analysis & Forecast 17.5.1. China Market Analysis 17.5.1.1. . Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Treatment 17.5.1.2.2. By Disease 17.5.1.2.3. By Cause 17.5.1.2.4. By Distribution Channel 17.5.2. Japan Market Analysis 17.5.2.1. Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Treatment 17.5.2.2.2. By Disease 17.5.2.2.3. By Cause 17.5.2.2.4. By Distribution Channel 17.5.3. South Korea Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Treatment 17.5.3.2.2. By Disease 17.5.3.2.3. By Cause 17.5.3.2.4. By Distribution Channel 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 2014-2022and Forecast 2023-2033 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Treatment 18.3.3. By Disease 18.3.4. By Cause 18.3.5. By Distribution Channel 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Treatment 18.4.3. By Disease 18.4.4. By Cause 18.4.5. By Distribution Channel 18.5. Country Level Analysis & Forecast 18.5.1. Australia Market Analysis 18.5.1.1. . Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Treatment 18.5.1.2.2. By Disease 18.5.1.2.3. By Cause 18.5.1.2.4. By Distribution Channel 18.5.2. New Zealand Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Treatment 18.5.2.2.2. By Disease 18.5.2.2.3. By Cause 18.5.2.2.4. By Distribution Channel 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2014-2022and Forecast 2023-2033 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Türkiye 19.3.1.3. Northern Africa 19.3.1.4. South Africa 19.3.1.5. Rest of Middle East and Africa 19.3.2. By Treatment 19.3.3. By Disease 19.3.4. By Cause 19.3.5. By Distribution Channel 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Treatment 19.4.3. By Disease 19.4.4. By Cause 19.4.5. By Distribution Channel 19.5. Country Level Analysis & Forecast 19.5.1. GCC Countries Market Analysis 19.5.1.1. . Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Treatment 19.5.1.2.2. By Disease 19.5.1.2.3. By Cause 19.5.1.2.4. By Distribution Channel 19.5.2. Türkiye Market Analysis 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Treatment 19.5.2.2.2. By Disease 19.5.2.2.3. By Cause 19.5.2.2.4. By Distribution Channel 19.5.3. Northern Africa Market Analysis 19.5.3.1. Introduction 19.5.3.2. Market Analysis and Forecast by Market Taxonomy 19.5.3.2.1. By Treatment 19.5.3.2.2. By Disease 19.5.3.2.3. By Cause 19.5.3.2.4. By Distribution Channel 19.5.4. South Africa Market Analysis 19.5.4.1. Introduction 19.5.4.2. Market Analysis and Forecast by Market Taxonomy 19.5.4.2.1. By Treatment 19.5.4.2.2. By Disease 19.5.4.2.3. By Cause 19.5.4.2.4. By Distribution Channel 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Share Analysis of Top Players 20.3. Market Presence Analysis 21. Competition Analysis 21.1. Competition Dashboard 21.2. Branding and Promotional Strategies 21.3. Key Development Analysis 21.4. Competition Deep Dive 21.4.1. Allergan, Inc 21.4.1.1. Overview 21.4.1.2. Product Portfolio 21.4.1.3. Key Financials 21.4.1.4. Sales Footprint 21.4.1.5. Strategy Overview 21.4.1.5.1. Marketing Strategy 21.4.1.5.2. Product Strategy 21.4.1.5.3. Channel Strategy 21.4.2. Novartis AG 21.4.2.1. Overview 21.4.2.2. Product Portfolio 21.4.2.3. Key Financials 21.4.2.4. Sales Footprint 21.4.2.5. Strategy Overview 21.4.2.5.1. Marketing Strategy 21.4.2.5.2. Product Strategy 21.4.2.5.3. Channel Strategy 21.4.3. Bausch Health Inc. 21.4.3.1. Overview 21.4.3.2. Product Portfolio 21.4.3.3. Key Financials 21.4.3.4. Sales Footprint 21.4.3.5. Strategy Overview 21.4.3.5.1. Marketing Strategy 21.4.3.5.2. Product Strategy 21.4.3.5.3. Channel Strategy 21.4.4. AbbVie Inc. 21.4.4.1. Overview 21.4.4.2. Product Portfolio 21.4.4.3. Key Financials 21.4.4.4. Sales Footprint 21.4.4.5. Strategy Overview 21.4.4.5.1. Marketing Strategy 21.4.4.5.2. Product Strategy 21.4.4.5.3. Channel Strategy 21.4.5. Tarsier Pharma 21.4.5.1. Overview 21.4.5.2. Product Portfolio 21.4.5.3. Key Financials 21.4.5.4. Sales Footprint 21.4.5.5. Strategy Overview 21.4.5.5.1. Marketing Strategy 21.4.5.5.2. Product Strategy 21.4.5.5.3. Channel Strategy 21.4.6. EyeGate Pharmaceuticals, Inc. 21.4.6.1. Overview 21.4.6.2. Product Portfolio 21.4.6.3. Key Financials 21.4.6.4. Sales Footprint 21.4.6.5. Strategy Overview 21.4.6.5.1. Marketing Strategy 21.4.6.5.2. Product Strategy 21.4.6.5.3. Channel Strategy 21.4.7. Alimera Science Inc 21.4.7.1. Overview 21.4.7.2. Product Portfolio 21.4.7.3. Key Financials 21.4.7.4. Sales Footprint 21.4.7.5. Strategy Overview 21.4.7.5.1. Marketing Strategy 21.4.7.5.2. Product Strategy 21.4.7.5.3. Channel Strategy 21.4.8. Eyepoint Pharmaceutical 21.4.8.1. Overview 21.4.8.2. Product Portfolio 21.4.8.3. Key Financials 21.4.8.4. Sales Footprint 21.4.8.5. Strategy Overview 21.4.8.5.1. Marketing Strategy 21.4.8.5.2. Product Strategy 21.4.8.5.3. Channel Strategy 21.4.9. Santen Pharmaceuticals 21.4.9.1. Overview 21.4.9.2. Product Portfolio 21.4.9.3. Key Financials 21.4.9.4. Sales Footprint 21.4.9.5. Strategy Overview 21.4.9.5.1. Marketing Strategy 21.4.9.5.2. Product Strategy 21.4.9.5.3. Channel Strategy 22. Assumptions and Acronyms Used 23. Research Methodology 図表リストTable 01: Global Uveitis Treatment Market Size (US$ Mn) Analysis and Forecast 2023-2033, by TreatmentTable 02: Global Uveitis Treatment Market Size (US$ Mn) Analysis and Forecast 2023-2033, by Disease Table 03: Global Uveitis Treatment Market Size (US$ Mn) Analysis and Forecast 2023-2033, by Cause Table 04: Global Uveitis Treatment Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel Table 05: North America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Country Table 06: North America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Treatment Table 07: North America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Disease Table 08: North America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Cause Table 09: North America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel Table 10: Latin America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Country Table 11: Latin America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Treatment Table 12: Latin America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Disease Table 13: Latin America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Cause Table 14: Latin America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel Table 15: Europe Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Country Table 16: Europe Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Treatment Table 17: Europe Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Disease Table 18: Europe Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Cause Table 19: Europe Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel Table 20: South Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Country Table 21: South Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Treatment Table 22: South Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Disease Table 23: South Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Cause Table 24: South Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel Table 25: East Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Country Table 26: East Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Treatment Table 27: East Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Disease Table 28: East Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Cause Table 29: East Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel Table 30: Oceania Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Country Table 31: Oceania Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Treatment Table 32: Oceania Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Disease Table 33: Oceania Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Cause Table 34: Oceania Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel Table 35: Middle East & Africa Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Country Table 36: Middle East & Africa Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Treatment Table 37: Middle East & Africa Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Disease Table 38: Middle East & Africa Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Cause Table 39: Middle East & Africa Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel
SummaryUveitis Treatment Market: Scope of the Report Table of Contents1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Treatment Adoption / Analysis 4.2. Disease Epidemiology 4.3. Pipeline Assessment 4.4. Patient Journey Analysis 4.5. PESTLE Analysis 4.6. Regulatory Scenario 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.1.3. Global Retinal Disorder Treatment Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Rise in Autoimmune Diseases 5.2.2. Rise in Infectious Uveitis 5.2.3. Treatment Adoption Rate 5.2.4. Growing Number of Service Providers 5.2.5. Rise in Infectious Illness Frequency in Developing Nations 5.2.6. Mergers and Acquisitions 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis - Impact Assessment 6.1. COVID-19 and Impact Analysis 6.1.1. By Treatment 6.1.2. By Disease 6.1.3. By Cause 6.1.4. By Distribution Channel 6.1.5. By Region 6.2. 2022 Market Scenario 7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2014-2022and Forecast, 2023-2033 7.1. Historical Market Value (US$ Mn) Analysis, 2014-2022 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2014-2022and Forecast 2023-2033, By Treatment 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Treatment, 2014-2022 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment, 2023-2033 8.3.1. Corticosteroids 8.3.2. Immunosuppressant 8.3.3. Monoclonal Antibodies 8.3.4. Cycloplegic Agents 8.3.5. Antibiotics 8.3.6. Antivirals 8.3.7. Antifungal 8.3.8. Analgesics 8.4. Market Attractiveness Analysis By Treatment 9. Global Market Analysis 2014-2022and Forecast 2023-2033, By Disease 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Disease, 2014-2022 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease, 2023-2033 9.3.1. Anterior Uveitis 9.3.2. Posterior Uveitis 9.3.3. Intermediate Uveitis 9.3.4. Panuveitis 9.4. Market Attractiveness Analysis By Disease 10. Global Market Analysis 2014-2022and Forecast 2023-2033, By Cause 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Cause, 2014-2022 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cause, 2023-2033 10.3.1. Infectious Uveitis 10.3.2. Non-infectious Uveitis 10.4. Market Attractiveness Analysis By Cause 11. Global Market Analysis 2014-2022and Forecast 2023-2033, by Distribution Channel 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2022 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2023-2033 11.3.1. Hospital Pharmacies 11.3.2. Retail Pharmacies 11.3.3. Online Pharmacies 11.3.4. Drug Stores 11.4. Market Attractiveness Analysis By Distribution Channel 12. Global Market Analysis 2014-2022and Forecast 2023-2033, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2022 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. South Asia 12.3.5. East Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2014-2022and Forecast 2023-2033 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Treatment 13.3.3. By Disease 13.3.4. By Cause 13.3.5. By Distribution Channel 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Treatment 13.4.3. By Disease 13.4.4. By Cause 13.4.5. By Distribution Channel 13.5. Country Level Analysis & Forecast 13.5.1. U.S. Market Analysis 13.5.1.1. . Introduction 13.5.1.2. Market Analysis and Forecast by Market Taxonomy 13.5.1.2.1. By Treatment 13.5.1.2.2. By Disease 13.5.1.2.3. By Cause 13.5.1.2.4. By Distribution Channel 13.5.2. Canada Market Analysis 13.5.2.1. Introduction 13.5.2.2. Market Analysis and Forecast by Market Taxonomy 13.5.2.2.1. By Treatment 13.5.2.2.2. By Disease 13.5.2.2.3. By Cause 13.5.2.2.4. By Distribution Channel 13.6. Market Trends 13.7. Key Market Participants - Intensity Mapping 13.8. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2014-2022 and Forecast 2023-2033 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.1.4.1. By Treatment 14.3.1.4.2. By Disease 14.3.1.4.3. By Cause 14.3.1.4.4. By Distribution Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Treatment 14.4.3. By Distribution Channel 14.5. Country Level Analysis & Forecast 14.5.1. Brazil Market Analysis 14.5.1.1. . Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Treatment 14.5.1.2.2. By Disease 14.5.1.2.3. By Cause 14.5.1.2.4. By Distribution Channel 14.5.2. Mexico Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Treatment 14.5.2.2.2. By Disease 14.5.2.2.3. By Cause 14.5.2.2.4. By Distribution Channel 14.5.3. Argentina Market Analysis 14.5.3.1. Introduction 14.5.3.2. Market Analysis and Forecast by Market Taxonomy 14.5.3.2.1. By Treatment 14.5.3.2.2. By Disease 14.5.3.2.3. By Cause 14.5.3.2.4. By Distribution Channel 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2014-2022and Forecast 2023-2033 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. France 15.3.1.3. Italy 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. BENELUX 15.3.1.8. Nordic Countries 15.3.1.9. Rest of Europe 15.3.2. By Treatment 15.3.3. By Disease 15.3.4. By Cause 15.3.5. By Distribution Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Treatment 15.4.3. By Disease 15.4.4. By Cause 15.4.5. By Distribution Channel 15.5. Country Level Analysis & Forecast 15.5.1. Germany Market Analysis 15.5.1.1. . Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Treatment 15.5.1.2.2. By Disease 15.5.1.2.3. By Cause 15.5.1.2.4. By Distribution Channel 15.5.2. France Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Treatment 15.5.2.2.2. By Disease 15.5.2.2.3. By Cause 15.5.2.2.4. By Distribution Channel 15.5.3. Italy Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Treatment 15.5.3.2.2. By Disease 15.5.3.2.3. By Cause 15.5.3.2.4. By Distribution Channel 15.5.4. U.K. Market Analysis 15.5.4.1. . Introduction 15.5.4.2. Market Analysis and Forecast by Market Taxonomy 15.5.4.2.1. By Treatment 15.5.4.2.2. By Disease 15.5.4.2.3. By Cause 15.5.4.2.4. By Distribution Channel 15.5.5. Spain Market Analysis 15.5.5.1. . Introduction 15.5.5.2. Market Analysis and Forecast by Market Taxonomy 15.5.5.2.1. By Treatment 15.5.5.2.2. By Disease 15.5.5.2.3. By Cause 15.5.5.2.4. By Distribution Channel 15.5.6. Russia Market Analysis 15.5.6.1. . Introduction 15.5.6.2. Market Analysis and Forecast by Market Taxonomy 15.5.6.2.1. By Treatment 15.5.6.2.2. By Disease 15.5.6.2.3. By Cause 15.5.6.2.4. By Distribution Channel 15.5.7. Nordic Countries Market Analysis 15.5.7.1. . Introduction 15.5.7.2. Market Analysis and Forecast by Market Taxonomy 15.5.7.2.1. By Treatment 15.5.7.2.2. By Disease 15.5.7.2.3. By Cause 15.5.7.2.4. By Distribution Channel 15.5.8. BENELUX Market Analysis 15.5.8.1. . Introduction 15.5.8.2. Market Analysis and Forecast by Market Taxonomy 15.5.8.2.1. By Treatment 15.5.8.2.2. By Disease 15.5.8.2.3. By Cause 15.5.8.2.4. By Distribution Channel 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2014-2022and Forecast 2023-2033 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Treatment 16.3.3. By Disease 16.3.4. By Cause 16.3.5. By Distribution Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Treatment 16.4.3. By Disease 16.4.4. By Cause 16.4.5. By Distribution Channel 16.5. Country Level Analysis & Forecast 16.5.1. India Market Analysis 16.5.1.1. . Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Treatment 16.5.1.2.2. By Disease 16.5.1.2.3. By Cause 16.5.1.2.4. By Distribution Channel 16.5.2. Thailand Market Analysis 16.5.2.1. . Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Treatment 16.5.2.2.2. By Disease 16.5.2.2.3. By Cause 16.5.2.2.4. By Distribution Channel 16.5.3. Indonesia Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Treatment 16.5.3.2.2. By Disease 16.5.3.2.3. By Cause 16.5.3.2.4. By Distribution Channel 16.5.4. Malaysia Market Analysis 16.5.4.1. Introduction 16.5.4.2. Market Analysis and Forecast by Market Taxonomy 16.5.4.2.1. By Treatment 16.5.4.2.2. By Disease 16.5.4.2.3. By Cause 16.5.4.2.4. By Distribution Channel 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. East Asia Market Analysis 2014-2022and Forecast 2023-2033 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Treatment 17.3.3. By Disease 17.3.4. By Cause 17.3.5. By Distribution Channel 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Treatment 17.4.3. By Disease 17.4.4. By Cause 17.4.5. By Distribution Channel 17.5. Country Level Analysis & Forecast 17.5.1. China Market Analysis 17.5.1.1. . Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Treatment 17.5.1.2.2. By Disease 17.5.1.2.3. By Cause 17.5.1.2.4. By Distribution Channel 17.5.2. Japan Market Analysis 17.5.2.1. Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Treatment 17.5.2.2.2. By Disease 17.5.2.2.3. By Cause 17.5.2.2.4. By Distribution Channel 17.5.3. South Korea Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Treatment 17.5.3.2.2. By Disease 17.5.3.2.3. By Cause 17.5.3.2.4. By Distribution Channel 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 2014-2022and Forecast 2023-2033 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Treatment 18.3.3. By Disease 18.3.4. By Cause 18.3.5. By Distribution Channel 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Treatment 18.4.3. By Disease 18.4.4. By Cause 18.4.5. By Distribution Channel 18.5. Country Level Analysis & Forecast 18.5.1. Australia Market Analysis 18.5.1.1. . Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Treatment 18.5.1.2.2. By Disease 18.5.1.2.3. By Cause 18.5.1.2.4. By Distribution Channel 18.5.2. New Zealand Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Treatment 18.5.2.2.2. By Disease 18.5.2.2.3. By Cause 18.5.2.2.4. By Distribution Channel 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2014-2022and Forecast 2023-2033 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014-2022 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Türkiye 19.3.1.3. Northern Africa 19.3.1.4. South Africa 19.3.1.5. Rest of Middle East and Africa 19.3.2. By Treatment 19.3.3. By Disease 19.3.4. By Cause 19.3.5. By Distribution Channel 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Treatment 19.4.3. By Disease 19.4.4. By Cause 19.4.5. By Distribution Channel 19.5. Country Level Analysis & Forecast 19.5.1. GCC Countries Market Analysis 19.5.1.1. . Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Treatment 19.5.1.2.2. By Disease 19.5.1.2.3. By Cause 19.5.1.2.4. By Distribution Channel 19.5.2. Türkiye Market Analysis 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Treatment 19.5.2.2.2. By Disease 19.5.2.2.3. By Cause 19.5.2.2.4. By Distribution Channel 19.5.3. Northern Africa Market Analysis 19.5.3.1. Introduction 19.5.3.2. Market Analysis and Forecast by Market Taxonomy 19.5.3.2.1. By Treatment 19.5.3.2.2. By Disease 19.5.3.2.3. By Cause 19.5.3.2.4. By Distribution Channel 19.5.4. South Africa Market Analysis 19.5.4.1. Introduction 19.5.4.2. Market Analysis and Forecast by Market Taxonomy 19.5.4.2.1. By Treatment 19.5.4.2.2. By Disease 19.5.4.2.3. By Cause 19.5.4.2.4. By Distribution Channel 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Share Analysis of Top Players 20.3. Market Presence Analysis 21. Competition Analysis 21.1. Competition Dashboard 21.2. Branding and Promotional Strategies 21.3. Key Development Analysis 21.4. Competition Deep Dive 21.4.1. Allergan, Inc 21.4.1.1. Overview 21.4.1.2. Product Portfolio 21.4.1.3. Key Financials 21.4.1.4. Sales Footprint 21.4.1.5. Strategy Overview 21.4.1.5.1. Marketing Strategy 21.4.1.5.2. Product Strategy 21.4.1.5.3. Channel Strategy 21.4.2. Novartis AG 21.4.2.1. Overview 21.4.2.2. Product Portfolio 21.4.2.3. Key Financials 21.4.2.4. Sales Footprint 21.4.2.5. Strategy Overview 21.4.2.5.1. Marketing Strategy 21.4.2.5.2. Product Strategy 21.4.2.5.3. Channel Strategy 21.4.3. Bausch Health Inc. 21.4.3.1. Overview 21.4.3.2. Product Portfolio 21.4.3.3. Key Financials 21.4.3.4. Sales Footprint 21.4.3.5. Strategy Overview 21.4.3.5.1. Marketing Strategy 21.4.3.5.2. Product Strategy 21.4.3.5.3. Channel Strategy 21.4.4. AbbVie Inc. 21.4.4.1. Overview 21.4.4.2. Product Portfolio 21.4.4.3. Key Financials 21.4.4.4. Sales Footprint 21.4.4.5. Strategy Overview 21.4.4.5.1. Marketing Strategy 21.4.4.5.2. Product Strategy 21.4.4.5.3. Channel Strategy 21.4.5. Tarsier Pharma 21.4.5.1. Overview 21.4.5.2. Product Portfolio 21.4.5.3. Key Financials 21.4.5.4. Sales Footprint 21.4.5.5. Strategy Overview 21.4.5.5.1. Marketing Strategy 21.4.5.5.2. Product Strategy 21.4.5.5.3. Channel Strategy 21.4.6. EyeGate Pharmaceuticals, Inc. 21.4.6.1. Overview 21.4.6.2. Product Portfolio 21.4.6.3. Key Financials 21.4.6.4. Sales Footprint 21.4.6.5. Strategy Overview 21.4.6.5.1. Marketing Strategy 21.4.6.5.2. Product Strategy 21.4.6.5.3. Channel Strategy 21.4.7. Alimera Science Inc 21.4.7.1. Overview 21.4.7.2. Product Portfolio 21.4.7.3. Key Financials 21.4.7.4. Sales Footprint 21.4.7.5. Strategy Overview 21.4.7.5.1. Marketing Strategy 21.4.7.5.2. Product Strategy 21.4.7.5.3. Channel Strategy 21.4.8. Eyepoint Pharmaceutical 21.4.8.1. Overview 21.4.8.2. Product Portfolio 21.4.8.3. Key Financials 21.4.8.4. Sales Footprint 21.4.8.5. Strategy Overview 21.4.8.5.1. Marketing Strategy 21.4.8.5.2. Product Strategy 21.4.8.5.3. Channel Strategy 21.4.9. Santen Pharmaceuticals 21.4.9.1. Overview 21.4.9.2. Product Portfolio 21.4.9.3. Key Financials 21.4.9.4. Sales Footprint 21.4.9.5. Strategy Overview 21.4.9.5.1. Marketing Strategy 21.4.9.5.2. Product Strategy 21.4.9.5.3. Channel Strategy 22. Assumptions and Acronyms Used 23. Research Methodology List of Tables/GraphsTable 01: Global Uveitis Treatment Market Size (US$ Mn) Analysis and Forecast 2023-2033, by TreatmentTable 02: Global Uveitis Treatment Market Size (US$ Mn) Analysis and Forecast 2023-2033, by Disease Table 03: Global Uveitis Treatment Market Size (US$ Mn) Analysis and Forecast 2023-2033, by Cause Table 04: Global Uveitis Treatment Market Value (US$ Mn) Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel Table 05: North America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Country Table 06: North America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Treatment Table 07: North America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Disease Table 08: North America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Cause Table 09: North America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel Table 10: Latin America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Country Table 11: Latin America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Treatment Table 12: Latin America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Disease Table 13: Latin America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Cause Table 14: Latin America Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel Table 15: Europe Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Country Table 16: Europe Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Treatment Table 17: Europe Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Disease Table 18: Europe Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Cause Table 19: Europe Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel Table 20: South Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Country Table 21: South Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Treatment Table 22: South Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Disease Table 23: South Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Cause Table 24: South Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel Table 25: East Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Country Table 26: East Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Treatment Table 27: East Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Disease Table 28: East Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Cause Table 29: East Asia Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel Table 30: Oceania Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Country Table 31: Oceania Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Treatment Table 32: Oceania Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Disease Table 33: Oceania Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Cause Table 34: Oceania Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel Table 35: Middle East & Africa Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Country Table 36: Middle East & Africa Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Treatment Table 37: Middle East & Africa Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Disease Table 38: Middle East & Africa Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Cause Table 39: Middle East & Africa Uveitis Treatment Market Size Analysis 2014-2022 and Forecast 2023-2033, by Distribution Channel
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
Persistence Market Research社の医療・製薬・メディカルデバイス分野での最新刊レポート
本レポートと同じKEY WORD（inflammatory）の最新刊レポートよくあるご質問Persistence Market Research社はどのような調査会社ですか?パーシスタンスマーケットリサーチ（Persistence Market Research/PMR）は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |
